Transforming Growth Factor-Beta
(TGF-
1
) Genotype and Lung
Allograft Fibrosis
Ahmed El-Gamel, FRCS, Mohammed R. Awad,
Philip S. Hasleton, MRCPath, Nizar A. Yonan, FRCS,
James A. Hutchinson, Colin S. Campbell, FRCS, Ali H. Rahman, FRCS,
Abdul K. Deiraniya, FRCS, Paul J. Sinnott, PhD, and
Ian V. Hutchinson, PhD
Background: TGF-
1
is a prosclerotic cytokine implicated in fibrotic processes. Fibrosis
of the pulmonary parenchyma and airways is a frequent presentation in lung transplant
recipients before and after transplantation. There are two genetic polymorphisms in the
DNA sequence encoding the leader sequence of the TGF-
1
protein, located at codon
10 (either leucine or proline) and at codon 25 (either arginine or proline). The codon
25 arginine allele is associated with higher TGF-
1
production by cells activated in
vitro. We tested the hypothesis that inheritance of alleles of the TGF-
1
gene
conferring higher production of TGF-
1
may be responsible for over-expression of
TGF-
1
in transplant recipients resulting in lung allograft fibrosis.
Methods: We extracted DNA from leukocytes collected from 91 pulmonary transplants
performed at our centre and 96 normal healthy volunteers between May 1990 and
September 1995. Part of the first exon was amplified by PCR. Samples were genotyped
by using sequence specific oligonucleotide probes.
Results: The distribution of codon 10 alleles was similar in a normal healthy control
group and in lung transplant recipients, regardless of their pretransplant lung
pathology. By contrast, there was a significant difference in the frequency of codon 25
alleles between the control and transplant groups. In the normal control group 81%
were codon 25 arginine/arginine (A/A) homozygotes, 19% were arginine/proline (A/P)
heterozygotes and none were proline/proline (P/P) homozygotes. The distribution of
codon 25 alleles was similar in lung transplant recipients who did not have a significant
fibrosis in pretransplant pathology, but in transplant recipients who came to
transplantation with lung fibrosis 98% (41 of 42 patients) were homozygous for the
codon 25 A/A allele (p .05). After lung transplantation 39 of 91 patients developed
lung allograft fibrosis, and of these 92.3% (36 of 39 recipients) were of homozygous
codon 25 A/A high TGF-
1
producer genotype (p .001). Lung transplant recipients
who were homozygous for both codon 10 L/L and codon 25 A/A showed poor survival
compared with all other TGF-
1
genotypes (p .03).
Conclusions: Homozygosity for arginine at codon 25 of the leader sequence of TGF-
1
,
that correlates with higher TGF-b production in vitro, is associated with fibrotic lung
pathology before lung transplantation and with the development of fibrosis in the graft.
In combination with the codon 10 leucine allele, homozygosity for the codon 25
From Cardiothoracic Transplant Unit, Wythenshawe Hospital
Manchester, UK, Tissue Typing Laboratory, Central Manches-
ter Health Trust, Manchester, UK, and School of Biological
Sciences, Manchester University, UK.
Submitted February 5, 1998; accepted July 10, 1998.
Paper presented in the ISHLT 17
th
Annual Meeting, April 2–5
th
,
1997, London, UK.
Reprint requests: Mr. A. El-Gamel, FRCS, Dept. Cardiothoracic
Surgery, Wythenshawe Hospital, Manchester M23 9LT, UK.
Copyright © 1999 by the International Society for Heart and
Lung Transplantation.
1053-2498/99/$–see front matter PII S0153-2498(98)00024-2
517